Back to 
FARALLON CAPITAL MANAGEMENT, L.L.C.
FARALLON CAPITAL MANAGEMENT, L.L.C.
FATE
Showing 0 of 15 quarters
Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in FATE THERAPEUTICS INC
No. Farallon Capital Management exited its FATE (Fate Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 31,900 shares worth $1.2M. Farallon Capital Management already held FATE in its Q4 2018 13F, the earliest on record, and held it in 14 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.